Point-of-Care (POC) Coagulation Testing Industry Expansion Forecast Showing Market Size of $1.52 Billion by 2030 at 4.1% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Point-of-Care (POC) Coagulation Testing Market During 2026–2030?
The point-of-care (poc) coagulation testing market size has shown consistent expansion in recent years. Projections indicate that this market will expand from $1.25 billion in 2025 to $1.3 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.2%. Historically, this growth is attributable to several factors, including the escalating incidence of cardiovascular ailments necessitating anticoagulation therapy, a heightened need for swift coagulation outcomes in operating theatres and intensive care units, the initial clinical uptake of optical and mechanical poc testing platforms, broader implementation of coagulation surveillance in both hospital and clinic environments, and increasing recognition of point-of-care diagnostics for enhancing treatment efficacy.
The point-of-care (poc) coagulation testing market is anticipated to experience consistent growth over the next few years. It is projected to achieve a size of $1.52 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 4.1%. This expansion during the forecast period is driven by a shift towards decentralized and home-based coagulation monitoring, enhanced utilization of electrochemical detection technologies, increasing procedure volumes within emergency and trauma care environments, expanded accessibility via retail and direct tender distribution channels, and a heightened focus on reducing turnaround times and enhancing therapy outcomes. Significant trends emerging during this period encompass the growing adoption of rapid bedside coagulation testing in critical and emergency care settings, an increasing deployment of PoC coagulation devices for anticoagulation therapy monitoring, a burgeoning preference for portable and handheld coagulation analyzers, the expansion of coagulation testing utilization in home care and outpatient environments, and a rising demand for real-time clinical decision support through near-patient testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
What Drivers Are Expected To Influence The Point-of-Care (POC) Coagulation Testing Market During The Forecast Period?
The increasing occurrence of cardiovascular diseases is projected to drive the expansion of the point-of-care (POC) coagulation testing market. Cardiovascular diseases (CVDs) are a category of conditions affecting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing is valuable in treating Cardiovascular diseases (CVDs) because it delivers real-time data on coagulation status, enabling prompt decisions on coagulation interventions and minimizing the risk of bleeding complications after cardiac surgery. For instance, in October 2024, figures from the Centers for Disease Control and Prevention, a US-based public health institute, indicated that in 2023, approximately 1 out of every 6 deaths from cardiovascular diseases occurred in adults younger than 65 years old, and a total of 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the rising incidence of cardiovascular diseases is propelling the growth of the point-of-care (POC) coagulation testing market.
How Are The Various Segments Of The Point-of-Care (POC) Coagulation Testing Market Categorized?
The point-of-care (poc) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
What Trends Are Affecting The Expansion Of The Point-of-Care (POC) Coagulation Testing Market?
Leading firms operating within the point-of-care (POC) coagulation testing market are concentrating on advancing connected POC coagulation solutions through strategic partnerships to gain an advantage. A strategic collaboration is a formal arrangement between two or more parties that work together to achieve specific, pre-defined goals that are mutually beneficial. For example, in January 2023, Jana care, a US-based company focused on creating biomarker assays for its unique digital health platform, teamed up with Roche Diagnostics, a Switzerland-based company that develops diagnostic tests, instruments, and digital solutions with the power to transform healthcare for people. This partnership aims to develop and distribute a point-of-care blood testing platform intended for screening chronic kidney disease and heart failure. This innovative platform will allow patients to carry out blood tests at home, with the results being reviewed remotely by clinicians.
Which Major Firms Influence Developments In The Point-of-Care (POC) Coagulation Testing Market?
Major companies operating in the point-of-care (poc) coagulation testing market are Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
Read the full point-of-care (poc) coagulation testing market report here:
Which Region Is Forecast To Lead The Point-of-Care (POC) Coagulation Testing Market In Terms Of Market Size?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2025. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Point-of-Care (POC) Coagulation Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Market 2026, By The Business Research Company
Point Of Care Poc Coagulation Testing Market Report 2026
Point Of Care Diagnostics Devices And Equipment Market Report 2026
Point Of Care Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
